Belvedere Trading »

Seres Therapeutics shares owned by Belvedere Trading

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2025-09-30 $235k 12k 19.24

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Strategy Cl A New (MSTR)
Apple (AAPL)
Broadcom (AVGO)
Spdr Gold Tr Gold Shs Call Option (GLD)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Amazon (AMZN)
Advanced Micro Devices (AMD)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Palantir Technologies Cl A (PLTR)

View all positions for Belvedere Trading

Top funds holding Seres Therapeutics

Flagship Ventures Management
Susquehanna International
Vanguard Group
Marshall Wace
Hudson Bay Capital Management
BlackRock
Vontobel Holding
J. Goldman & Co
Citadel Advisors
Geode Capital Management
Caption Management
Jane Street
Charles Schwab Investment Management
State Street Corporation
Schonfeld Strategic Advisors

View all funds holding Seres Therapeutics